Latest data from July 29, 2022
Number of Health Center respondents = 47 (75% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 | 12,257 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) | 73.10% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 | 1,882 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) | 73.43% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, Antigen)2 | Patients Tested Positive, Virus Detection (PCR, Antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 19.38% | 20.88% |
| White, Hispanic/Latino Patients | 6.92% | 10.31% |
| Black/African American, Non-Hispanic/Latino Patients | 16.08% | 15.99% |
| Black/African American, Hispanic/Latino Patients | 2.11% | 1.91% |
| Asian Patients3 | 4.41% | 3.88% |
| American Indian/Alaska Native Patients3 | 0.73% | 1.54% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.52% | 0.80% |
| Patients with More Than One Race3 | 2.09% | 1.97% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 19.82% | 21.31% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 3.38% | 2.98% |
| Unreported/Refused to Report Race and Ethnicity | 24.56% | 18.44% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 1,227 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 91.66% |
| COVID-19 Immunization Series Completed | 1,156 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 84.61% |
| COVID-19 Immunization Series Additional | 3,851 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 84.72% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 7.01% | 12.02% | 12.93% |
| White, Hispanic/Latino Patients | 9.05% | 8.13% | 8.78% |
| Black/African American, Non-Hispanic/Latino Patients | 32.03% | 26.56% | 21.37% |
| Black/African American, Hispanic/Latino Patients | 2.36% | 2.16% | 1.74% |
| Asian Patients3 | 8.80% | 3.63% | 12.33% |
| American Indian/Alaska Native Patients3 | 0.98% | 0.52% | 3.58% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.73% | 0.69% | 0.39% |
| Patients with More Than One Race3 | 3.50% | 3.63% | 2.78% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 19.56% | 20.76% | 20.72% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 4.07% | 3.98% | 3.22% |
| Unreported/Refused to Report Race and Ethnicity | 11.90% | 17.91% | 12.15% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 17.02% |
| 1 to 24 Hours | 31.91% |
| More Than 24 Hours | 48.94% |
| N/A | 2.13% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 10.64% |
| Staffing to administer the vaccine | 25.53% |
| Vaccine confidence | 36.17% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 2.13% |
| Other | 10.64% |
| None | 36.17% |
Operations and Staff
| Metrics | Value |
|---|---|
| COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program | 29.79% |
| Average Percent of Health Center Visits Conducted Virtually | 13.51% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 17.02% |
| Number of Mobile Van Sites | 8 |
| Number of Pop-up Clinics | 58 |
| Number of School-Based Vaccination Sites | 0 |
| Number of Family Vaccination Clinics | 64 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 8.51% |
| Refer patients to another organization that provides monoclonal antibody therapies | 51.06% |
| None | 40.43% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 0.00% |
| Patient awareness/education | 4.26% |
| Staffing capacity | 19.15% |
| Therapy administration/onsite logistics | 25.53% |
| Other | 0.00% |
| None | 59.57% |
Test Kit Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program | 31 |
| Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program | 10,053 |
Test Kit Distribution Methods4
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 90.32% |
| Provided to General Public Who Came to the Health Center | 45.16% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 22.58% |
| Provided at Other Community Events | 38.71% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 12.90% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 29.03% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 35.48% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 29.03% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 19.35% |
| Other | 19.35% |
N95 Mask Distribution
| Metrics | Value |
|---|---|
| Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask Program | 19 |
| Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program | 12,209 |
N95 Mask Distribution Methods5
| Metrics | Value |
|---|---|
| Provided to Existing Health Center Patients | 94.74% |
| Provided to General Public Who Came to the Health Center | 52.63% |
| Provided at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) | 26.32% |
| Provided at Other Community Events | 36.84% |
| Provided to migratory/seasonal agricultural workers directly or through partnerships with community organizations serving these individuals | 26.32% |
| Provided to individuals with limited English proficiency directly or through partnerships with community organizations serving these individuals | 42.11% |
| Provided to older adults and/or individuals with disabilities directly or through partnerships with community organizations serving these individuals | 36.84% |
| Provided to school-age children and/or their families directly or through partnerships with schools | 42.11% |
| Provided to individuals living in HUD-assisted housing and/or individuals experiencing homelessness directly or through partnerships with local housing authorities | 21.05% |
| Other | 15.79% |
Oral Antiviral Medication Distribution
| Metrics | Value |
|---|---|
| Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program | 14 |
| Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication | 62.50% |
Oral Antiviral Medication Distribution by Race and Ethnicity
| Race/Ethnicity | Value |
|---|---|
| White, Non-Hispanic/Latino Patients | 27.08% |
| White, Hispanic/Latino Patients | 18.33% |
| Black/African American, Non-Hispanic/Latino Patients | 13.33% |
| Black/African American, Hispanic/Latino Patients | 0.83% |
| Asian Patients3 | 7.92% |
| American Indian/Alaska Native Patients3 | 0.83% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.00% |
| Patients with More Than One Race3 | 5.00% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 16.25% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) | 0.83% |
| Unreported/Refused to Report Race and Ethnicity | 9.58% |
Oral Antiviral Medication Distribution by Population Type
| Metrics | Value |
|---|---|
| Migratory/Agricultural Workers | 0.42% |
| Patients Experiencing Homelessness | 1.67% |
| Patients Who Are Residents of Public Housing | 30.00% |
| Patients with Limited English Proficiency | 13.33% |
| Children Under 18 Years of Age | 0.83% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.
5 Percentages are calculated using the number of health centers that have distributed N95 masks received through the HRSA Health Center COVID-19 N95 Mask Program as the denominator.
Date Last Reviewed: